Immunocytochemistry for hepatocyte nuclear factor-1β (HNF-11β): A marker for ovarian clear cell carcinoma

Diagnostic Cytopathology

Volumn 35, Issue 4, 2007, Pages 193-197

  Kato, Noriko ^a   Toukairin, Michiko ^b   Asanuma, Izumi ^b   Motoyama, Teiichi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Kahoku Hospital   (Japan)

Author keywords

Ascites; Clear cell carcinoma; HNF 1 ; Immunocytochemistry; Ovary

Indexed keywords

CELL NUCLEUS ANTIGEN; EPITOPE; HEPATOCYTE NUCLEAR FACTOR 1BETA; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES FLUID CYTOLOGY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; NUDE MOUSE; OVARY ADENOCARCINOMA; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOCARCINOMA, CLEAR CELL; ALCOHOLS; ANIMALS; CELL LINE, TUMOR; FEMALE; FIXATIVES; HEATING; HEPATOCYTE NUCLEAR FACTOR 1-BETA; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICROWAVES; OVARIAN NEOPLASMS; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL; VAGINAL SMEARS;

EID: 34047115849     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20623     Document Type: Article

References (13)

1. Tammela J, Geisler JP, Eskew PN, Jr, Geisler HE. Clear cell carcinoma of the ovary: poor prognosis compared to serous carcinoma. Eur J GynaecolOncol 1998;19:438-440.
2. Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol 1996;60:412-417.
3. Ito H, Hirasawa T, Yasuda M, Osamura RY, Tsutsumi Y. Excessive formation of basement membrane substance in clear cell carcinoma of the ovary: Diagnostic value of the "raspberry body" in ascites cytology. Diagn Cytopathol 1997;16:500-504.
4. Schwartz DR, Kardia SL, Shedden KA, et al. Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas. Cancer Res 2002;62:4722-4729.
5. Tsuchiya A, Sakamoto M, Yasuda J, et al. Expression profiling in ovarian clear cell carcinoma. Identification of hepatocyte nuclear factor-1β as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol 2003;163:2503-2512.
6. Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1β (HNF-1β) in clear cell tumors and endometriosis of the ovary. Mod Pathol 2006;19:83-89.
7. Yamada K, Tachibana T, Hashimoto H, et al. Establishment and characterization of cell lines derived from serous adenocarcinoma (JHOS-2) and clear cell adenocarcinoma (JHOC-5, JHOC-6) of human ovary. Hum Cell 1999;12:131-138.
8. Yonamine K, Hayashi K, Iida T. Establishment and characterization of human ovarian clear cell adenocarcinoma cell lines (SMOV-2), and its cytotoxity by anticancer agents. Hum Cell 1999;12:139-148.
9. Mikami Y, Hata S, Melamed J, Moriya T, Manabe T. Basement membrane material in ovarian clear cell carcinoma: correlation with growth pattern and nuclear grade. Int J Gynecol Pathol 1999;18:52-57.
10. Miller RT, Swanson PE, Wick MR. Fixation and epitope retrieval in diagnostic immunohistochemistry: a concise review with practical considerations. Appl Immunohistochem 2000;8:228-235.
11. Nara-Inui H, Akutsu H, Kyogoku Y. Alcohol induced B-A transition of DNAs with different base compositions studied by circular dichroism. J Biochem 1985;98:629-636.
12. Clark GR, Squire CJ, Baker LJ, Martin RF, White J. Intermolecular interactions and water structure in a condensed phase B-DNA crystal. Nucleic Acid Res 2000;28:1259-1265.
13. Senkel S, Lucas B, Klein-Hitpass L, Ryffel GU. Identification of target genes of the transcription factor HNF-1β and HNF-α in a human embryonic kidney cell lines. Biochem Biophys Acta 2005;1731:179-190.